跳至主要内容
临床试验/JPRN-UMIN000015966
JPRN-UMIN000015966招募中未知

Clinical benefit of measurement of advanced glycogen endproduct level in type 2 diabetes - Clinical benefit of measurement of advanced glycogen endproduct level in type 2 diabetes

Human Ethics Review Committee of Kumamoto University0 个研究点目标入组 200 人开始时间: 2014年12月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 100years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients with infectious disease 2. Patients with acute/chronic inflammatory disease 3. Patients with cancer 4. Patients with acute cerebrovascular disease 5. Patients with severe hepatic disease 6. Patients with severe respiratory 7. Patients with mental disorder 8. Patients decided from attended doctors not to be recruited in the study

研究者

发起方
Human Ethics Review Committee of Kumamoto University

相似试验

Clinical benefit of measurement of advanced glycogen... | 临床试验